Uncategorized

In addition to offloading the Sound United segment for $350 million, Masimo lowered its 2025 profit forecast to account for tariffs and disclosed a cyberattack.

The abrupt end of $11 billion in public health grants nationally disrupted a program in Colorado that provides residents critical access to behavioral health and substance abuse support.

AdvaMed and its British counterpart called for urgent action to ensure the situation “does not devolve into a crisis.”

Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for vaccines and sought greater clarity: “I don’t know what they’re talking about.”

Although the job market did not pick up in April, layoffs were down year over year and month over month, according to BioSpace tallies. Meanwhile, Amgen, Novartis, Regeneron and Roche announced U.S. manufacturing investments that are sparking job creation.

The Massachusetts biotech will focus its efforts and resources into cemsidomide, an oral drug candidate being trialed for multiple myeloma and non-Hodgkin lymphoma.

En un nuevo estudio se ha demostrado que el cerebro, y en concreto ciertas neuronas hipotalámicas, es capaz de modificar la composición de la microbiota intestinal, al menos en ratones; y puede hacerlo en cuestión de horas. Este descubrimiento representa un cambio de paradigma q …

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying innovation and trade barriers disrupting supply chains.

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the market position of Wegovy. But Eli Lilly’s Zepbound is quickly gaining ground, with sales just $300 million behind Wegovy in Q1.

The lawsuit alleges the Trump administration overstepped its authority in reshaping the federal health department and asked the court to reinstate workers laid off last month.